Skip to main content
Year archive

EMYRIA LIMITED — 2020 filings

All 90 regulatory filings released by EMYRIA LIMITED (EMD) in 2020, sourced directly from the official regulator.

90 Filings
2020 Period
2020 filings (90)
Filing Released Lang
Appendix 2A and Notice Under Section 708A 17 pages 328.6KB
Regulatory Filings
2020-12-21 English
Emyria to Accelerate Drug Development with $1.2m Placement 3 pages 145.5KB
Capital/Financing Update
2020-12-15 English
Proposed issue of Securities - EMD 6 pages 30.9KB
Capital/Financing Update
2020-12-15 English
Proposed issue of Securities - EMD 6 pages 29.4KB
Capital/Financing Update
2020-12-15 English
Proposed issue of Securities - EMD 6 pages 29.5KB
Capital/Financing Update
2020-12-15 English
Emyria to Benefit from Final TGA Ruling on CBD Medicines 3 pages 145.6KB
Regulatory Filings
2020-12-15 English
Trading Halt 2 pages 521.2KB
Regulatory Filings
2020-12-13 English
Product Launch Update 22 pages 3.6MB
Investor Presentation
2020-12-07 English
Emyria Sees Strong Interest in IBS Study 2 pages 255.3KB
Regulatory Filings
2020-12-02 English
Emyria Launches Drug Development Program Based on RWE 4 pages 328.6KB
Capital/Financing Update
2020-11-24 English
Emyria Partners with Thought Leaders in Psychedelic Therapy 3 pages 209.8KB
Capital/Financing Update
2020-11-18 English
Change of Director's Interest Notice SW 5 pages 246.9KB
Director's Dealing
2020-11-15 English
Exercise Price of Options 1 page 112.6KB
Capital/Financing Update
2020-11-12 English
Annual General Meeting Presentation 28 pages 8.1MB
Regulatory Filings
2020-11-12 English
Results of Meeting 2 pages 131.3KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-12 English
Appendix 3G 12 pages 281.5KB
Share Issue/Capital Change
2020-11-12 English
Change of Director's Interest Notice * 4 8 pages 365.3KB
Director's Dealing
2020-11-12 English
Emyria Enters Data Deal with Zelira to Support Autism Trial 3 pages 249.5KB
Regulatory Filings
2020-11-08 English
Release of Unlisted Options from Escrow 1 page 149.
Capital/Financing Update
2020-11-05 English
Emyria receives $954,000 R&D tax incentive refund 2 pages 199.5KB
Capital/Financing Update
2020-11-01 English
Appendix 4C - Quarterly 10 pages 370.3KB
Interim / Quarterly Report
2020-10-28 English
Change of Director's Interest Notice AV 2 pages 134.1KB
Director's Dealing
2020-10-22 English
Emyria Enters into Partnership with Sapphire Medical Clinics 3 pages 262.0KB
Regulatory Filings
2020-10-20 English
Webinar on Global Partnership with Sapphire Medical Clinics 2 pages 194.8KB
Investor Presentation
2020-10-20 English
Investor Presentation 32 pages 12.4MB
Investor Presentation
2020-10-13 English
Annual Report to shareholders 100 pages 2.3MB
Regulatory Filings
2020-10-08 English
Appendix 4G 13 pages 294.4KB
Governance Information
2020-10-08 English
Notice of Annual General Meeting/Proxy Form 32 pages 909.2KB
AGM Information
2020-10-07 English
Letter to Shareholders - Annual General Meeting 4 pages 856.2KB
AGM Information
2020-10-07 English
ZLD: Signs Real-World Data Agreement for Zenivol with Emyria 3 pages 240.2KB
Regulatory Filings
2020-09-29 English
Annual General Meeting Date 2 pages 307.5KB
AGM Information
2020-09-29 English
Emyria Signs Real-World Data Agreement with Zelira 2 pages 210.9KB
Capital/Financing Update
2020-09-29 English
Amended Change in substantial holding SW 4 pages 143.9KB
Major Shareholding Notification
2020-09-23 English
Change in substantial holding CD 3 pages 110.2KB
Major Shareholding Notification
2020-09-17 English
Change in substantial holding MS 3 pages 104.4KB
Major Shareholding Notification
2020-09-17 English
Change in substantial holding MW 3 pages 1.5MB
Regulatory Filings
2020-09-17 English
Change in substantial holding SW 3 pages 138.3KB
Major Shareholding Notification
2020-09-17 English
Results of Meeting 2 pages 151.8KB
Declaration of Voting Results & Voting Rights Announcements
2020-09-17 English
Emerald Partners with Mt Sinai for Openly Service 2 pages 178.6KB
Regulatory Filings
2020-09-16 English
Emerald Receives TGA Registration for Openly App 2 pages 175.7KB
Regulatory Filings
2020-09-14 English
Emerald Supports Interim Decision for Evidence-Based OTC CBD 2 pages 178.1KB
Regulatory Filings
2020-09-10 English
Issue of Placement Shares 2 pages 149.4KB
Capital/Financing Update
2020-09-06 English
Appendix 2A and Notice Under Section 708A 16 pages 332.1KB
Capital/Financing Update
2020-09-06 English
Change of Registered Office 1 page 112.5KB
Regulatory Filings
2020-09-01 English
Preliminary Final Report and Full Year Statutory Accounts 60 pages 1.0MB
Annual Report
2020-08-30 English
Emerald Clinics Successfully Raises $2.2m in Placement 2 pages 177.4KB
Capital/Financing Update
2020-08-27 English
Proposed issue of Securities - EMD 5 pages 27.7KB
Capital/Financing Update
2020-08-27 English
Trading Halt 2 pages 354.0KB
Capital/Financing Update
2020-08-26 English
Company Update 18 pages 6.3MB
Investor Presentation
2020-08-18 English
Record Appointments International Expansion and Name Change 2 pages 202.4KB
Regulatory Filings
2020-08-13 English
Notice of General Meeting/Proxy Form 8 pages 864.2KB
Proxy Solicitation & Information Statement
2020-08-13 English
Letter to Shareholders - General Meeting 4 pages 791.9KB
Proxy Solicitation & Information Statement
2020-08-13 English
Emerald Signs RWE Contract with Canopy Growth UK Company 3 pages 210.5KB
Capital/Financing Update
2020-08-09 English
Appendix 4C - Quarterly 10 pages 491.2KB
Interim / Quarterly Report
2020-07-30 English
Investor Presentation 25 pages 13.2MB
Investor Presentation
2020-06-24 English
EMDs Digital Health Platform Expands with New Technology 3 pages 211.7KB
Capital/Financing Update
2020-06-21 English
Emerald Clinics Investor Webinar 1 page 119.6KB
Regulatory Filings
2020-06-21 English
Trading Halt 2 pages 222.2KB
Regulatory Filings
2020-06-17 English
EMD Program Manager of National Clinical Data and Analytics 3 pages 231.3KB
Regulatory Filings
2020-05-10 English
Appendix 4C - Quarterly 10 pages 364.2KB
Interim / Quarterly Report
2020-04-29 English
Change in substantial holding CD 3 pages 122.4KB
Major Shareholding Notification
2020-04-19 English
COVID-19 Market Update 3 pages 207.7KB
Capital/Financing Update
2020-03-25 English
Change of Director's Interest Notice SW 3 pages 132.3KB
Director's Dealing
2020-03-16 English
Change of Director's Interest Notice SW 3 pages 132.0KB
Director's Dealing
2020-03-10 English
Investor Presentation 23 pages 5.1MB
Investor Presentation
2020-03-04 English
Half Yearly Report and Accounts 23 pages 639.5KB
Interim / Quarterly Report
2020-02-27 English
ZLD: Phase 1 Opioid Reduction Clinical Trial Fully Enrolled 3 pages 170.3KB
Regulatory Filings
2020-02-26 English
Emerald to Conduct Opioid Sparing Clinical Trial for Zelira 2 pages 201.9KB
Regulatory Filings
2020-02-26 English
Emerald to Present Keynote at UK Govt Backed Conference 2 pages 206.1KB
Regulatory Filings
2020-02-17 English
Emerald Clinics Lists on the ASX 3 pages 176.8KB
Capital/Financing Update
2020-02-11 English
Becoming a substantial holder 3 pages 124.9KB
Major Shareholding Notification
2020-02-10 English
Becoming a substantial holder 3 pages 81.4KB
Major Shareholding Notification
2020-02-10 English
Becoming a substantial holder 3 pages 1.3MB
Regulatory Filings
2020-02-10 English
Becoming a substantial holder 3 pages 86.6KB
Major Shareholding Notification
2020-02-10 English
Initial Director's Interest Notice * 5 10 pages 196.4KB
Director's Dealing
2020-02-10 English
Admission and Commencement of Quotation 2 pages 126.5KB
Regulatory Filings
2020-02-09 English
Appendix 1A 1 page 110.1KB
Regulatory Filings
2020-02-09 English
Information Form and Checklist 17 pages 271.2KB
Capital/Financing Update
2020-02-09 English
Prospectus 178 pages 3.8MB
Capital/Financing Update
2020-02-09 English
Constitution 56 pages 404.5KB
Governance Information
2020-02-09 English
Financial Statements to 30 June 2018 25 pages 2.2MB
Annual Report
2020-02-09 English
Financial Statements to 30 June 2019 32 pages 818.7KB
Annual Report
2020-02-09 English
Employee Securities Incentive Plan 26 pages 241.8KB
Regulatory Filings
2020-02-09 English
Securities Trading Policy 8 pages 155.1KB
Governance Information
2020-02-09 English
Distribution Schedule 1 page 63.6KB
Major Shareholding Notification
2020-02-09 English
Top 20 Shareholders 2 pages 79.1KB
Major Shareholding Notification
2020-02-09 English
Proforma Statement of Financial Position 2 pages 240.4KB
Capital/Financing Update
2020-02-09 English
Updated Statement of Commitments 2 pages 215.4KB
Capital/Financing Update
2020-02-09 English
Capital Structure 2 pages 186.3KB
Capital/Financing Update
2020-02-09 English
Corporate Governance Statement 15 pages 233.7KB
Governance Information
2020-02-09 English